AI Verdict
REGN has stronger fundamentals based on our AI analysis.
BAX vs REGN Fundamental Comparison
| Metric | BAX | REGN |
|---|---|---|
| Revenue | $2.7B | $3.6B |
| Net Income | $-15.0M | $727.2M |
| Net Margin | -0.6% | 20.2% |
| ROE | -0.2% | 2.3% |
| ROA | -0.1% | 1.8% |
| Current Ratio | 1.85x | 3.57x |
| Debt/Equity | 1.56x | 0.06x |
| EPS | $-0.03 | $6.75 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
BAX vs REGN: Frequently Asked Questions
Is BAX or REGN the better stock in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), REGN has stronger fundamentals. BAX is graded C (84% confidence) while REGN is graded A (80% confidence). This is not investment advice.
How does BAX compare to REGN fundamentally?
BAXTER INTERNATIONAL INC has ROE of -0.2% vs REGENERON PHARMACEUTICALS, INC.'s 2.3%. Net margins are -0.6% vs 20.2% respectively.
Which stock pays higher dividends, BAX or REGN?
BAX has a dividend yield of N/A or no dividend while REGN has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in BAX or REGN for long term?
For long-term investing, consider that BAX has a C grade with 84% confidence, while REGN has a A grade with 80% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about BAX vs REGN?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For BAX vs REGN, the AI consensus favors REGN based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.